Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4995)
All Articles published online
|
Sep 21, 2011 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i35/4023.htm |
| Number | Citing Articles |
| 1 |
Xiaolei Liu, Jia Huang, Liguo Liu, Rong Liu. MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC‑SD cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10506
|
| 2 |
Hong-Beum Kim, Won Jin Cho, Nam Gyu Choi, Sung-Soo Kim, Jun Hee Park, Hee-Jeong Lee, Sang Gon Park. Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer. Annals of Surgical Treatment and Research 2017; 92(1): 15 doi: 10.4174/astr.2017.92.1.15
|
| 3 |
Wen-Cheng Chung, Junqing Wang, Yunyun Zhou, Keli Xu. KrasG12D upregulates Notch signaling to induce gallbladder tumorigenesis in mice. Oncoscience 2017; 4(9-10): 131 doi: 10.18632/oncoscience.368
|
| 4 |
Daniel H. Ahn, Tanios Bekaii-Saab. Textbook of Gastrointestinal Oncology. 2019; : 185 doi: 10.1007/978-3-030-18890-0_11
|
| 5 |
Nilofer Azad, Zishuo Hu, Ilyas Sahin, Renuka Iyer, Olivia Aranha, Howard Hochster, Priyadarshini Pathak, Andrew Scott Paulson, Aparna Kalyan, Chih-Yi Liao, Nguyen Tran, Robin K Kelley, Gregory Heestand, David Cosgrove, Anthony El-Khoueiry, Mitesh Borad, Nashat Y Gabrail, Umair Majeed, Lingling Du, Suneel Kamath, Nathan Shumway, Rachna Shroff, Lipika Goyal, Minori Rosales, Milind Javle. COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC. Future Oncology 2024; 20(30): 2241 doi: 10.1080/14796694.2024.2351351
|
| 6 |
Amir A. Rahnemai-Azar, Timothy M. Pawlik. Cholangiocarcinoma: shedding light on the most promising drugs in clinical development. Expert Opinion on Investigational Drugs 2021; 30(4): 419 doi: 10.1080/13543784.2021.1897103
|
| 7 |
Qingmiao Shi, Chen Xue, Yifan Zeng, Xin Yuan, Qingfei Chu, Shuwen Jiang, Jinzhi Wang, Yaqi Zhang, Danhua Zhu, Lanjuan Li. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01828-x
|
| 8 |
Toshio Kokuryo, Yukihiro Yokoyama, Masato Nagino. Recent advances in cancer stem cell research for cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012; 19(6): 606 doi: 10.1007/s00534-012-0542-6
|
| 9 |
Paxton V. Dickson, Stephen W. Behrman. Distal Cholangiocarcinoma. Surgical Clinics of North America 2014; 94(2): 325 doi: 10.1016/j.suc.2013.12.004
|
| 10 |
Hakan Soylu, Nuray Acar, Ozlem Ozbey, Betul Unal, Ismail Turker Koksal, Ibrahim Bassorgun, Akif Ciftcioglu, Ismail Ustunel. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma. Pathology & Oncology Research 2016; 22(1): 87 doi: 10.1007/s12253-015-9983-y
|
| 11 |
Javier Vaquero, Nathalie Guedj, Audrey Clapéron, Thanh Huong Nguyen Ho-Bouldoires, Valérie Paradis, Laura Fouassier. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. Journal of Hepatology 2017; 66(2): 424 doi: 10.1016/j.jhep.2016.09.010
|
| 12 |
Amir A. Rahnemai-Azar, Arezou Abbasi, Alexandra W. Acher, Sharon M. Weber, Timothy M. Pawlik. Emerging pathways for precision medicine in management of cholangiocarcinoma. Surgical Oncology 2020; 35: 47 doi: 10.1016/j.suronc.2020.08.008
|
| 13 |
Mingyu Yang, Meng Li, Zhuozhen Lyu, Zhen Yang. Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?. Cancer Management and Research 2023; : 335 doi: 10.2147/CMAR.S406150
|
| 14 |
Jason K. Sicklick, Paul T. Fanta. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 150 doi: 10.1016/B978-0-323-34062-5.00122-9
|
| 15 |
Amartej Merla, Kenneth G. Liu, Lakshmi Rajdev. Targeted Therapy in Biliary Tract Cancers. Current Treatment Options in Oncology 2015; 16(10) doi: 10.1007/s11864-015-0366-0
|
| 16 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 17 |
Soomin Ahn, Jiyeon Hyeon, Cheol-Keun Park. Notchl and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2013; 12(3): 286 doi: 10.1016/S1499-3872(13)60046-6
|
| 18 |
P. Baichan, P. Naicker, J. W. S. Devar, M. Smith, G. P. Candy, E. Nweke. Targeting gallbladder cancer: a pathway based perspective. Molecular Biology Reports 2020; 47(3): 2361 doi: 10.1007/s11033-020-05269-x
|
| 19 |
Meng-Xi Xiu, Yuan-Meng Liu, Bo-hai Kuang. <p>The Role of DLLs in Cancer: A Novel Therapeutic Target</p>. OncoTargets and Therapy 2020; : 3881 doi: 10.2147/OTT.S244860
|
| 20 |
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. Cancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
|
| 21 |
|
| 22 |
Francesca Borlak, Anja Reutzel-Selke, Anja Schirmeier, Julia Gogolok, Ellen von Hoerschelmann, Igor M. Sauer, Johann Pratschke, Marcus Bahra, Rosa B. Schmuck. Notch Signaling Pathway in Pancreatobiliary Tumors. Medicina 2021; 57(2): 105 doi: 10.3390/medicina57020105
|
| 23 |
Benjamin Rahmani, Jason Gandhi, Gunjan Joshi, Noel L. Smith, Inefta Reid, Sardar Ali Khan. The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract. Current Diabetes Reviews 2020; 16(9): 931 doi: 10.2174/1573399816666200305094727
|
| 24 |
Hee Jin Lee, Dae-Woon Eom, Gil Hyun Kang, Sang Hak Han, Gab Jin Cheon, Ho-Suk Oh, Koon Hee Han, Heui June Ahn, Hyuk-Jai Jang, Myoung Sik Han. Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells. Modern Pathology 2013; 26(8): 1123 doi: 10.1038/modpathol.2012.163
|
| 25 |
Shuichi Aoki, Masamichi Mizuma, Yayoi Takahashi, Yoichi Haji, Ryo Okada, Tomoya Abe, Hideaki Karasawa, Keiichi Tamai, Takaho Okada, Takanori Morikawa, Hiroki Hayashi, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh, Yu Katayose, Michiaki Unno. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2919-4
|
| 26 |
WEN-RUI WU, RUI ZHANG, XIANG-DE SHI, MAN-SHENG ZHU, LEI-BO XU, HONG ZENG, CHAO LIU. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro. Oncology Reports 2014; 31(6): 2515 doi: 10.3892/or.2014.3123
|
| 27 |
Fernando Ortiz-Martínez, Francisco José Gutiérrez-Aviñó, Elena Sanmartín, Eloy Pomares-Navarro, Cristina Villalba-Riquelme, Araceli García-Martínez, Enrique Lerma, Gloria Peiró. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3 + Tregs. Experimental and Molecular Pathology 2016; 100(3): 460 doi: 10.1016/j.yexmp.2016.04.006
|
| 28 |
Jacklyn M. Nemunaitis, Ursa Brown-Glabeman, Heloisa Soares, Jessica Belmonte, Ben Liem, Itzhak Nir, Victor Phuoc, Rama R. Gullapalli. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4575-3
|
| 29 |
Ahmed S. Doghish, Heba M. Midan, Abdullah M.M. Elbadry, Samar F. Darwish, Nehal I. Rizk, Bassant O. Ziada, Amir S. Elbokhomy, Mahmoud A. Elrebehy, Mohammed S. Elballal, Hussein M. El-Husseiny, Sherif S. Abdel Mageed, Ahmed I. Abulsoud. The potential role of miRNAs in the pathogenesis of gallbladder cancer – A focus on signaling pathways interplay. Pathology - Research and Practice 2023; 248: 154682 doi: 10.1016/j.prp.2023.154682
|
| 30 |
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
|
| 31 |
Biao Fan, Yann Malato, Diego F. Calvisi, Syed Naqvi, Nataliya Razumilava, Silvia Ribback, Gregory J. Gores, Frank Dombrowski, Matthias Evert, Xin Chen, Holger Willenbring. Cholangiocarcinomas can originate from hepatocytes in mice. Journal of Clinical Investigation 2012; 122(8): 2911 doi: 10.1172/JCI63212
|
| 32 |
Kara M. Keplinger, Mark Bloomston. Anatomy and Embryology of the Biliary Tract. Surgical Clinics of North America 2014; 94(2): 203 doi: 10.1016/j.suc.2014.01.001
|
| 33 |
Jurairat Jongthawin, Porncheera Chusorn, Anchalee Techasen, Watcharin Loilome, Thidarut Boonmars, Raynoo Thanan, Anucha Puapairoj, Narong Khuntikeo, Wichittra Tassaneeyakul, Puangrat Yongvanit, Nisana Namwat. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Tumor Biology 2014; 35(8): 8051 doi: 10.1007/s13277-014-2021-y
|
| 34 |
Mona El Khatib, Przemyslaw Bozko, Vindhya Palagani, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz, Peiwen Fei. Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo. PLoS ONE 2013; 8(10): e77433 doi: 10.1371/journal.pone.0077433
|